Literature DB >> 15500576

Sedative effects and serum drug concentrations of oxymorphone and metabolites after subcutaneous administration of a liposome-encapsulated formulation in dogs.

L J Smith1, L Krugner-Higby, L A Trepanier, D E Flaska, V Joers, T D Heath.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2004        PMID： 15500576     DOI： 10.1111/j.1365-2885.2004.00582.x

Source DB:  PubMed          Journal:  J Vet Pharmacol Ther        ISSN： 0140-7783            Impact factor:   1.786


× No keyword cloud information.
  4 in total

1.  Pharmacokinetics of oxymorphone in titi monkeys (Callicebus spp.) and rhesus macaques (Macaca mulatta).

Authors:  Kristi R Kelly; Bruno H Pypendop; J Kevin Grayson; Scott D Stanley; Kari L Christe; Laura M Summers; Nicholas W Lerche
Journal:  J Am Assoc Lab Anim Sci       Date:  2011-03       Impact factor: 1.232

2.  Pharmacokinetics and behavioral effects of an extended-release, liposome-encapsulated preparation of oxymorphone in rhesus macaques.

Authors:  Lisa Krugner-Higby; Butch KuKanich; Brynn Schmidt; Timothy D Heath; Carolyn Brown; Lesley J Smith
Journal:  J Pharmacol Exp Ther       Date:  2009-04-07       Impact factor: 4.030

3.  A comparison of the effects of hydromorphone HCl and a novel extended release hydromorphone on arterial blood gas values in conscious healthy dogs.

Authors:  L A Wunsch; B K Schmidt; L A Krugner-Higby; L J Smith
Journal:  Res Vet Sci       Date:  2009-08-18       Impact factor: 2.534

4.  Pharmacokinetics of a controlled-release liposome-encapsulated hydromorphone administered to healthy dogs.

Authors:  L J Smith; B KuKanich; B K Hogan; C Brown; T D Heath; L A Krugner-Higby
Journal:  J Vet Pharmacol Ther       Date:  2008-10       Impact factor: 1.786
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.